CA2089157A1 - Liver fluke diagnostic system - Google Patents
Liver fluke diagnostic systemInfo
- Publication number
- CA2089157A1 CA2089157A1 CA 2089157 CA2089157A CA2089157A1 CA 2089157 A1 CA2089157 A1 CA 2089157A1 CA 2089157 CA2089157 CA 2089157 CA 2089157 A CA2089157 A CA 2089157A CA 2089157 A1 CA2089157 A1 CA 2089157A1
- Authority
- CA
- Canada
- Prior art keywords
- antibody
- binding region
- glutamic acid
- peptide
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Current techniques for the diagnosis of liver fluke infection in animals involve examination of faecal matter for parasite eggs and as such are difficult to use outside a research environment.
The invention provides an antibody-binding region of a liver fluke tegument protein comprising a peptide with an amino-acid sequence: Asparagine-Lysine-Glutamic acid-Glycine-Glutamic acid-Proline-Glutamic acid as well as antibodies raised against it. Either the antibody-binding sequence or antibodies raised against it can be used in a test system for the diagnosis of liver fluke infection.
The invention provides an antibody-binding region of a liver fluke tegument protein comprising a peptide with an amino-acid sequence: Asparagine-Lysine-Glutamic acid-Glycine-Glutamic acid-Proline-Glutamic acid as well as antibodies raised against it. Either the antibody-binding sequence or antibodies raised against it can be used in a test system for the diagnosis of liver fluke infection.
Description
W0 92/03735 f~ 1 PCI`/GB91/01398 ,,,.,.. ,. - 1 "LIVER FLUKE DIAGNOSTIC SYSTEM"
The present invention relates to liver fluke epitopes or antibody-binding regions and to a diagnostic test kit for the identification of the liver fluke parasite in livestock using the epitopes, or antibodies raised against them.
Infect;on of sheep and cattle by the L;ver Fluke parasite (Fasciola heDatica~ causes severe economic loss to the livestock industries of countries with temperate climates. In some areas of Europe up to 80 per cent o~ animals show evidence of preYious infection at slaughter.
Horses and goats can also be infected, as can humans. Current farming policy in areas where the fluke i5 endemic involves the ~egular dosing of herds with anthelminthic drugs. This is an expensive procedure and may lead to the accumulation of undesirable drug residues in the animals' tissues. Current techn;ques for the identification of infected animals in a herd are based on the examination of faecal ma~ter for the large hyaline, thin-shelled, operculate eggs of the parasite. This requires personnel skilled in the identi;ication of helminth eggs and as such is not generally applied outside research centres.
8ritish Patent Specification No. 2169606A relates to a liver fluke antigen which is specific to the juvenile stage of ,Fasciola, organisms and which i's suitable ~or use as a Yaccine to protect against the earlier stages of primary infection. Also disclosed are antibodies against the ~uvenile-specific antigen which are said to be useful in extracting juvenile-specific antig~ns from juvenile Fasciola.
- , . . . - , 2 0 8 ~ ~ 5 7 PCr/GB91/01398 _ z _ PCT Publ ication No. W088/01277 d;scloses a recombinant GNA molecule comprising at least one nucleotide sequence wh;ch codes for all or a portion of a helmlnth paras;te antigen. Also d;sclosed are a synthetic polypept;de displaying the antigenicity of all or a portion of a helm;nth parasite antigen and vacc;ne compos;t;ons der;ved therefrom.
However, neither of these documents discloses a diagnostic system for the detection of ~luke infection or a specific antibody~binding region of a Fasciola heoatica tegument protein.
The object of the present invention is to provide a cheap, user-friendly diagnostic system to test for fluke infection. This would enable the stock raiser to administer anthelminthics only to those animals in a herd that were actually -infected, leading to a con5iderable reduction in the costs involved in the raising of cattle for both milk and meat production. It also has ~he adYantage that it would reduce the likelihood of the development of drug resistance in the parasites.
When animals are ;nfected with L;ver Flukes their im~une system rap;dly begins to make protein molecules called antibodies which bind specifically to the outer surface (tegument) o~ the parasite. The - amino ac;d sequence o~ part of a tegument protein has been determined and it has been found to contain a region which has the same seven am;no ac;ds arranged ;n a tandem repeat;ng array. These amino acids can act as an epitope (ant;body binding reg;on) and bind Liver Fluke specif;c antibodies. This sequence has been synthesised and incorporated in an immunoassay which can dist;nguish between sera from infected and uninfected cattle and may thus be used to test for infection by the Liver Fluke.
According to the present invention there is provided an antibody-bindin~ region of a Fascio?a heDat;ca tegument protein compris;ng a peptide having the amino-acid se~uence:-Asparagine-Lys;ne-Glutam;c ac;d-Glyc;ne-Glutamic ac;d-Proline-Glutamic acid.
.
- ' " '"'` ' .
W O 92/03735 2 0 8 91~ 7 PCT/GB91/01398 Preferably the antibody-binding region comprises a tandem repeat of the peptide as defined above. A ~andem repeat may be defined as multiple copies of the same sequence lying in series. Most preferably the antibody~binding re~ion comprises the peptide tandemly repeated five times. The antibody-binding region may comprise the peptide as defined above, or a tandem repeat thereof, flanked at either end thereof by other amino-acid sequences. Al~ernatively, the antibody-binding region may be linked to another conventional carrier molecule.
It will be appreciated that non essential amino acids of the abo~e peptide sequence may be var;ed without significantly affect;ng the ;mmunological or biological activity of the antibody-binding region.
Therefore, within the scope of this ;nvent;on are ;ncluded antibody-b;nd;ng regions comprising analogs of the above peptide sequence in which non-essent;al amino~acids are replaced, the ant;body-b;nd;ng aet;v;ty be;ng retained. The antibody-binding region of the ;nvention may also comprise a tandem repeat of such analogs.
The invention also provides a DNA sequence encoding the above defined antibody-b;nding reg;on or wh;ch on expression codes for a peptide having similar ;mmunolog;cal or biological ac~ivity to the antibody-binding region defined above.
The invention also provides antibodies directed against an antibody~binding region of a Fasciola hePatica tegument protein comprisina a peptide having the amino-ac;d sequence:-Asparagine-Lysine-Glutamic acid-Glycine-Glu~amic acid-Proline-Glutamic acid.
The antibodies may be monoclonal or polyclonal.
In a further aspect the invention provides a diagnostic test kit for the ;dentificat;on of Fasc;ola he~at;ca ;n l;vestock comprising an antibody-binding region or an antibody as defined above or a combination of both.
WO 92/03735 ~ , PCr/GB91/01398 The diagnostic test kit may be that for any conventional d;agnost;c test.
The invention relates to antibody-b;nd;ng reg;ons, DNA sequences and ntibod;es in ;solated or b;olog;cally pure form.
A cDNA l;brary of Fasc;ola hepat;ca was produced as described in Huynh et al, in ~he phage vector ~gtll (Sigma Chemical Company, Faney Road, Poole, BH17 7NA, England). Screening this library wi~h antisera from domestic farm animals experimentally infected with Fasciola hepatica was carr;ed out by transferring lysogenic plaques to nitrocellulose filters and screening as described by Sambrook et al (1). This enabled the identification of recombinant plaques containing inserts coding for Fasciola hepatica proteins which are immunogenic in the mammalian host.
One of these inserts is linked to DNA encoding the ~-gaiactosidase gene. When expressed, it produced a fusion protein (FPI). FP1 was excised from polyacrylamide gels (PAGE) ~nd an emulsion was prepared with Complete Freunds Adjuvant. M;ce were ;noculated (0.5 ml intra-peritoneally) and after two weeks boos~ed with Incomplete Freunds Adjuvant and FP1. After a further two weeks sera were collected and tested for immunoreactivity. In the juvenile fluke (6 weeks post excystment) there is strong bindlng to both the tegumental syncytium and to the tegumental cells. In the mature fluke (more than 12 weeks post excystment) the binding to the tegument is much reduced but there ;s strong b;nd;ng to the walls of the oviduct. This indicates that the insert contains DNA encoding at least a portion of a tegumental protein.
Agarose gel electrophoresis showed the insert to be about 1000 bp (base pairs) with an internal EcoR1 site which on cleavage yields two fragments of 800 bp and 200 bp. SDS PAGE analysis of the induced insert expressed as a ~-galactosidase fusion protein shows a difference of about 30 kDa (kilo Daltons) between E. coli ~-galactosidase and the fusion protein suggesting that most of the insert is ~ranslated.
~5 The fusion protein was excised from ~gtll by digestion with the restriction enzyme EcoR1, separated by PAGE and DNA fragments were - : , .
W O 92/03735 2 ~ 8 91 5 7 PCT/GB91/01398 , `- `. .
_ 5 _ isolated from the gels and prepared for ligation into the M13 cloning vector (Sigma Chemical Company, Fancy Road, Poole, BH17 7NA, England) using T4 polymerase (Sambrook et al (2)). The DNA thus expressed in the M13 cloning vector was used for dideoxynucleotide sequencing.
Figure 1 shows part ot the sequence of the 200 bp fragment. A notable feature of this part of the sequence is the presence of a tandemly repeated heptamer. Peptides corresponding to two of ~he possible reading frames of the heptamer were synthesised (Houghten, 1985) as either 3 x (NKEGEPE) or 3 x (RTRKENQ). The other reading frame contained a "stop" codon. In order to determine the correct reading frame an ELISA (enzyme linked immunosorbent assay) was performed using homogenised fluke antigen in the solid phase (Trudgett, Anderson &
Hanna, 1988). Sera from infected cattle were titrated in the presence and absence of each of the peptides (used at 1 ~g/ml). The presence of 3 x (NKEGEPE) resulted in a 50% reduction in the binding of the anti-fluke a~tibody, thus indicating that this peptide conta;ned a major B-cell ep;tope from F. hePatica. This result was confirmed by coating ELISA plates with 3 x (NKEGEPE) and then titrating sera from infected and control animals. Cattle sera from two weeks post-infection had titres (reciprocal of dilution giving significant binding) of the order of 200-4000 by this technique.
The sequence also contains a potential site for cleavage by membrane bound proteases (Arg-Lys), which allows the parasite to shed the antibody-binding s;te, thus evading the host's immune response. For this reason it is considere: that the peptide of the invention would not be suitable for vaccina~ion purposes.
The FP1 fusion protein has been shown to be associated with the tegument and tegumental cells of juvenile flukes. In the adul~ it is observed in association with the female reproductive system. In this respect it is similar to the epitopes of the T1 ant;gen which have been detected at these sites using monoclonal antibodies ~Hanna, Trudgett and Anderson, 1988). The molecular ratio (Mr) of the isogenic protein as determined by immunoblott;ng is not s;gnificantly different from that of the T1 antigen (Hanna and Trudgett, 1983). It is thus soncluded that the FP1 insert contains part of the gene for the T1 .
!
w o 92/03735 ~ 0 8 ~ PCT/GB91/0139 antigen. This protein provides the major immunogenic stimulus whilst the fluke is migrating through the host tissue towards the bile ducts.
(Hanna, 1980). It is believed to play a major role in the evasion of the host ;mmune system as it is continuously shed from the tegument during this period. The tandemly repeated heptameric B cell epitope may be involved in this phenomenon as may the site for proteolytic cleavage ;n prox;mity to th;s reg;on of the molecule.
Serial serum samples taken from exper;mentally infected cattle and sheep have indicated that a rise in specific antibody levels against the antibody-binding region of the present invention can be de~ected from one week post infection.
,Abbreviations 15 A Alanine T Threonine V Valine C Cysteine L Leucine Y Tyrosine I Isoleucine N Asparagine P Proline Q Glutamine 20 F Phenylalanine D Aspartic acid W Tryptophan E Glutamic acid M Methionine K Lys;ne G Glycine R Arginine S Serine H Histid;ne References Duffus, W.P.H. and Franks, D. (1981~. The interaction in vitro between bovine immunoglobulin and juvenile Fasciola heuatica. Parasitology 82:1.
Hanna, R.E.B. (1980) Fasciola hepatica: glycocalyx replacement in the juvenile as a possible mechanism for protection against host immunity.
Experimental Parasitology 50:103.
Hanna, R.E.B. and Trudgett, A. (1983) Fasciola hepatica,: development of monoclonal antibodies and their use to characterize a glycocalyx antigen in migrating flukes. Parasite Immunology 5:409.
.
w o s2/0373s 2 0 8 915 7 PCT/GB91/01398 ~ r~,~
Hanna, R.E.B., Trudgett, A. and Anderson, A. (1988) Fasciola hepatica:
development of monoclonal antibodies against somatic antigens and their characterization by ultrastructural localization of antibody binding.
Journal of Helminthology 62:15 Houghten R.A. (1985) General method for the rapid synthesis of large numbers of peptides: spec;ficity of an antigen-antibody interaction at ~he level of ind;v;dual am;no-acids. Proc. Natl. Acad. Sci. USA
82:5131-5135 Huynh, T. et al in DNA cloning : a practical approach. (1985) ed. D.M.
Glover. IRL Press, Oxford.
Trudgett A, Anderson A. and Hanna R.E.B. (1988) Use of immunosorbent-purified antigens of Fasciola hepatica in enzyme immunoassays. Research in Veterinary Science 44:262 Sambrook, Fritsch and Maniat;s (eds) (1) in Molecular Cloning. 2nd Edition. Cold Spring Harbor Laboratory Press, pages 1216-1220.
Sambrook, Fritsch and Maniatis (eds) (2) in Molecular Cloning. 2nd Edition. Cold Spring Harbor Laboratory Press, page 1323.
;
........... . . .
The present invention relates to liver fluke epitopes or antibody-binding regions and to a diagnostic test kit for the identification of the liver fluke parasite in livestock using the epitopes, or antibodies raised against them.
Infect;on of sheep and cattle by the L;ver Fluke parasite (Fasciola heDatica~ causes severe economic loss to the livestock industries of countries with temperate climates. In some areas of Europe up to 80 per cent o~ animals show evidence of preYious infection at slaughter.
Horses and goats can also be infected, as can humans. Current farming policy in areas where the fluke i5 endemic involves the ~egular dosing of herds with anthelminthic drugs. This is an expensive procedure and may lead to the accumulation of undesirable drug residues in the animals' tissues. Current techn;ques for the identification of infected animals in a herd are based on the examination of faecal ma~ter for the large hyaline, thin-shelled, operculate eggs of the parasite. This requires personnel skilled in the identi;ication of helminth eggs and as such is not generally applied outside research centres.
8ritish Patent Specification No. 2169606A relates to a liver fluke antigen which is specific to the juvenile stage of ,Fasciola, organisms and which i's suitable ~or use as a Yaccine to protect against the earlier stages of primary infection. Also disclosed are antibodies against the ~uvenile-specific antigen which are said to be useful in extracting juvenile-specific antig~ns from juvenile Fasciola.
- , . . . - , 2 0 8 ~ ~ 5 7 PCr/GB91/01398 _ z _ PCT Publ ication No. W088/01277 d;scloses a recombinant GNA molecule comprising at least one nucleotide sequence wh;ch codes for all or a portion of a helmlnth paras;te antigen. Also d;sclosed are a synthetic polypept;de displaying the antigenicity of all or a portion of a helm;nth parasite antigen and vacc;ne compos;t;ons der;ved therefrom.
However, neither of these documents discloses a diagnostic system for the detection of ~luke infection or a specific antibody~binding region of a Fasciola heoatica tegument protein.
The object of the present invention is to provide a cheap, user-friendly diagnostic system to test for fluke infection. This would enable the stock raiser to administer anthelminthics only to those animals in a herd that were actually -infected, leading to a con5iderable reduction in the costs involved in the raising of cattle for both milk and meat production. It also has ~he adYantage that it would reduce the likelihood of the development of drug resistance in the parasites.
When animals are ;nfected with L;ver Flukes their im~une system rap;dly begins to make protein molecules called antibodies which bind specifically to the outer surface (tegument) o~ the parasite. The - amino ac;d sequence o~ part of a tegument protein has been determined and it has been found to contain a region which has the same seven am;no ac;ds arranged ;n a tandem repeat;ng array. These amino acids can act as an epitope (ant;body binding reg;on) and bind Liver Fluke specif;c antibodies. This sequence has been synthesised and incorporated in an immunoassay which can dist;nguish between sera from infected and uninfected cattle and may thus be used to test for infection by the Liver Fluke.
According to the present invention there is provided an antibody-bindin~ region of a Fascio?a heDat;ca tegument protein compris;ng a peptide having the amino-acid se~uence:-Asparagine-Lys;ne-Glutam;c ac;d-Glyc;ne-Glutamic ac;d-Proline-Glutamic acid.
.
- ' " '"'` ' .
W O 92/03735 2 0 8 91~ 7 PCT/GB91/01398 Preferably the antibody-binding region comprises a tandem repeat of the peptide as defined above. A ~andem repeat may be defined as multiple copies of the same sequence lying in series. Most preferably the antibody~binding re~ion comprises the peptide tandemly repeated five times. The antibody-binding region may comprise the peptide as defined above, or a tandem repeat thereof, flanked at either end thereof by other amino-acid sequences. Al~ernatively, the antibody-binding region may be linked to another conventional carrier molecule.
It will be appreciated that non essential amino acids of the abo~e peptide sequence may be var;ed without significantly affect;ng the ;mmunological or biological activity of the antibody-binding region.
Therefore, within the scope of this ;nvent;on are ;ncluded antibody-b;nd;ng regions comprising analogs of the above peptide sequence in which non-essent;al amino~acids are replaced, the ant;body-b;nd;ng aet;v;ty be;ng retained. The antibody-binding region of the ;nvention may also comprise a tandem repeat of such analogs.
The invention also provides a DNA sequence encoding the above defined antibody-b;nding reg;on or wh;ch on expression codes for a peptide having similar ;mmunolog;cal or biological ac~ivity to the antibody-binding region defined above.
The invention also provides antibodies directed against an antibody~binding region of a Fasciola hePatica tegument protein comprisina a peptide having the amino-ac;d sequence:-Asparagine-Lysine-Glutamic acid-Glycine-Glu~amic acid-Proline-Glutamic acid.
The antibodies may be monoclonal or polyclonal.
In a further aspect the invention provides a diagnostic test kit for the ;dentificat;on of Fasc;ola he~at;ca ;n l;vestock comprising an antibody-binding region or an antibody as defined above or a combination of both.
WO 92/03735 ~ , PCr/GB91/01398 The diagnostic test kit may be that for any conventional d;agnost;c test.
The invention relates to antibody-b;nd;ng reg;ons, DNA sequences and ntibod;es in ;solated or b;olog;cally pure form.
A cDNA l;brary of Fasc;ola hepat;ca was produced as described in Huynh et al, in ~he phage vector ~gtll (Sigma Chemical Company, Faney Road, Poole, BH17 7NA, England). Screening this library wi~h antisera from domestic farm animals experimentally infected with Fasciola hepatica was carr;ed out by transferring lysogenic plaques to nitrocellulose filters and screening as described by Sambrook et al (1). This enabled the identification of recombinant plaques containing inserts coding for Fasciola hepatica proteins which are immunogenic in the mammalian host.
One of these inserts is linked to DNA encoding the ~-gaiactosidase gene. When expressed, it produced a fusion protein (FPI). FP1 was excised from polyacrylamide gels (PAGE) ~nd an emulsion was prepared with Complete Freunds Adjuvant. M;ce were ;noculated (0.5 ml intra-peritoneally) and after two weeks boos~ed with Incomplete Freunds Adjuvant and FP1. After a further two weeks sera were collected and tested for immunoreactivity. In the juvenile fluke (6 weeks post excystment) there is strong bindlng to both the tegumental syncytium and to the tegumental cells. In the mature fluke (more than 12 weeks post excystment) the binding to the tegument is much reduced but there ;s strong b;nd;ng to the walls of the oviduct. This indicates that the insert contains DNA encoding at least a portion of a tegumental protein.
Agarose gel electrophoresis showed the insert to be about 1000 bp (base pairs) with an internal EcoR1 site which on cleavage yields two fragments of 800 bp and 200 bp. SDS PAGE analysis of the induced insert expressed as a ~-galactosidase fusion protein shows a difference of about 30 kDa (kilo Daltons) between E. coli ~-galactosidase and the fusion protein suggesting that most of the insert is ~ranslated.
~5 The fusion protein was excised from ~gtll by digestion with the restriction enzyme EcoR1, separated by PAGE and DNA fragments were - : , .
W O 92/03735 2 ~ 8 91 5 7 PCT/GB91/01398 , `- `. .
_ 5 _ isolated from the gels and prepared for ligation into the M13 cloning vector (Sigma Chemical Company, Fancy Road, Poole, BH17 7NA, England) using T4 polymerase (Sambrook et al (2)). The DNA thus expressed in the M13 cloning vector was used for dideoxynucleotide sequencing.
Figure 1 shows part ot the sequence of the 200 bp fragment. A notable feature of this part of the sequence is the presence of a tandemly repeated heptamer. Peptides corresponding to two of ~he possible reading frames of the heptamer were synthesised (Houghten, 1985) as either 3 x (NKEGEPE) or 3 x (RTRKENQ). The other reading frame contained a "stop" codon. In order to determine the correct reading frame an ELISA (enzyme linked immunosorbent assay) was performed using homogenised fluke antigen in the solid phase (Trudgett, Anderson &
Hanna, 1988). Sera from infected cattle were titrated in the presence and absence of each of the peptides (used at 1 ~g/ml). The presence of 3 x (NKEGEPE) resulted in a 50% reduction in the binding of the anti-fluke a~tibody, thus indicating that this peptide conta;ned a major B-cell ep;tope from F. hePatica. This result was confirmed by coating ELISA plates with 3 x (NKEGEPE) and then titrating sera from infected and control animals. Cattle sera from two weeks post-infection had titres (reciprocal of dilution giving significant binding) of the order of 200-4000 by this technique.
The sequence also contains a potential site for cleavage by membrane bound proteases (Arg-Lys), which allows the parasite to shed the antibody-binding s;te, thus evading the host's immune response. For this reason it is considere: that the peptide of the invention would not be suitable for vaccina~ion purposes.
The FP1 fusion protein has been shown to be associated with the tegument and tegumental cells of juvenile flukes. In the adul~ it is observed in association with the female reproductive system. In this respect it is similar to the epitopes of the T1 ant;gen which have been detected at these sites using monoclonal antibodies ~Hanna, Trudgett and Anderson, 1988). The molecular ratio (Mr) of the isogenic protein as determined by immunoblott;ng is not s;gnificantly different from that of the T1 antigen (Hanna and Trudgett, 1983). It is thus soncluded that the FP1 insert contains part of the gene for the T1 .
!
w o 92/03735 ~ 0 8 ~ PCT/GB91/0139 antigen. This protein provides the major immunogenic stimulus whilst the fluke is migrating through the host tissue towards the bile ducts.
(Hanna, 1980). It is believed to play a major role in the evasion of the host ;mmune system as it is continuously shed from the tegument during this period. The tandemly repeated heptameric B cell epitope may be involved in this phenomenon as may the site for proteolytic cleavage ;n prox;mity to th;s reg;on of the molecule.
Serial serum samples taken from exper;mentally infected cattle and sheep have indicated that a rise in specific antibody levels against the antibody-binding region of the present invention can be de~ected from one week post infection.
,Abbreviations 15 A Alanine T Threonine V Valine C Cysteine L Leucine Y Tyrosine I Isoleucine N Asparagine P Proline Q Glutamine 20 F Phenylalanine D Aspartic acid W Tryptophan E Glutamic acid M Methionine K Lys;ne G Glycine R Arginine S Serine H Histid;ne References Duffus, W.P.H. and Franks, D. (1981~. The interaction in vitro between bovine immunoglobulin and juvenile Fasciola heuatica. Parasitology 82:1.
Hanna, R.E.B. (1980) Fasciola hepatica: glycocalyx replacement in the juvenile as a possible mechanism for protection against host immunity.
Experimental Parasitology 50:103.
Hanna, R.E.B. and Trudgett, A. (1983) Fasciola hepatica,: development of monoclonal antibodies and their use to characterize a glycocalyx antigen in migrating flukes. Parasite Immunology 5:409.
.
w o s2/0373s 2 0 8 915 7 PCT/GB91/01398 ~ r~,~
Hanna, R.E.B., Trudgett, A. and Anderson, A. (1988) Fasciola hepatica:
development of monoclonal antibodies against somatic antigens and their characterization by ultrastructural localization of antibody binding.
Journal of Helminthology 62:15 Houghten R.A. (1985) General method for the rapid synthesis of large numbers of peptides: spec;ficity of an antigen-antibody interaction at ~he level of ind;v;dual am;no-acids. Proc. Natl. Acad. Sci. USA
82:5131-5135 Huynh, T. et al in DNA cloning : a practical approach. (1985) ed. D.M.
Glover. IRL Press, Oxford.
Trudgett A, Anderson A. and Hanna R.E.B. (1988) Use of immunosorbent-purified antigens of Fasciola hepatica in enzyme immunoassays. Research in Veterinary Science 44:262 Sambrook, Fritsch and Maniat;s (eds) (1) in Molecular Cloning. 2nd Edition. Cold Spring Harbor Laboratory Press, pages 1216-1220.
Sambrook, Fritsch and Maniatis (eds) (2) in Molecular Cloning. 2nd Edition. Cold Spring Harbor Laboratory Press, page 1323.
;
........... . . .
Claims (10)
1. An antibody-binding region of a Fasciola hepatica tegument protein comprising a peptide having the amino acid sequence:-Aspararagine-Lysine-Glutamic acid-Glycine-Glutamic acid-Proline-Glutamic acid, or an analog thereof also having antibody-binding activity.
2. An antibody-binding region as claimed in claim 1 comprising a tandem repeat of the said peptide or analog thereof.
3. An antibody-binding region as claimed in claim 2 wherein the peptide or analog thereof is tandemly repeated five times.
4. An antibody-binding region as claimed in any preceding claim which is flanked at either end thereof by other amino-acid sequences.
5. A DNA sequence encoding an antibody-binding region as claimed in any preceding claim.
6. An antibody directed against an antibody-binding region of a Fasciola hepatica tegument protein comprising a peptide having the amino-acid sequence:-Asparagine-Lysine-Glutamic acid-Glycine-Glutamic acid-Proline-Glutamic acid, or an analog thereof also having antibody-binding activity.
7. An antibody directed against an antibody-binding region as claimed in any of claims 1 to 4.
8. An antibody as claimed in claim 6 or 7 which is a polyclonal antibody.
9. An antibody as claimed in claim 6 or 7 which is a monoclonal antibody.
10. A diagnostic test kit for the identification of Fasciola hepatica in livestock comprising a reagent selected from an antibody-binding region as claimed in any of claims 1 to 4, an antibody as claimed in any of claims 6 to 9 or a combination of both.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909018238A GB9018238D0 (en) | 1990-08-20 | 1990-08-20 | Liver fluke diagnostic system |
| GB9018238.7 | 1990-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2089157A1 true CA2089157A1 (en) | 1992-02-21 |
Family
ID=10680939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2089157 Abandoned CA2089157A1 (en) | 1990-08-20 | 1991-08-16 | Liver fluke diagnostic system |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU8426591A (en) |
| CA (1) | CA2089157A1 (en) |
| GB (2) | GB9018238D0 (en) |
| WO (1) | WO1992003735A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2172492A1 (en) * | 1993-09-28 | 1995-04-06 | Elza Nicole Theresia Meeusen | Protective antigens against parasites |
| CN105277720B (en) * | 2015-10-08 | 2017-03-22 | 深圳华康生物医学工程有限公司 | ELISA kit for detection of liver fluke IgG4 antibody and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988001277A1 (en) * | 1986-08-18 | 1988-02-25 | The Australian National University | Helminth parasite vaccine |
| WO1990008819A1 (en) * | 1989-01-31 | 1990-08-09 | Daratech Pty. Ltd. | Vaccine for the preventative treatment of infection of liver fluke in ruminants |
-
1990
- 1990-08-20 GB GB909018238A patent/GB9018238D0/en active Pending
-
1991
- 1991-08-16 GB GB9117831A patent/GB2249097A/en not_active Withdrawn
- 1991-08-16 AU AU84265/91A patent/AU8426591A/en not_active Withdrawn
- 1991-08-16 WO PCT/GB1991/001398 patent/WO1992003735A1/en not_active Application Discontinuation
- 1991-08-16 CA CA 2089157 patent/CA2089157A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB9117831D0 (en) | 1991-10-09 |
| GB9018238D0 (en) | 1990-10-03 |
| GB2249097A (en) | 1992-04-29 |
| WO1992003735A1 (en) | 1992-03-05 |
| AU8426591A (en) | 1992-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Astrin et al. | Endogenous viral genes are non-essential in the chicken | |
| US4751181A (en) | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases | |
| Brockes et al. | Studies on cultured rat Schwann cells. III. Assays for peripheral myelin proteins | |
| Mäntyjärvi et al. | Complementary DNA cloning of the predominant allergen of bovine dander: a new member in the lipocalin family | |
| EP0445135A1 (en) | Immogenically active fractions of borrelia burgdorferi. | |
| Christensen et al. | The nucleolar protein, B-36, contains a glycine and dimethylarginine-rich sequence conserved in several other nuclear RNA-binding proteins | |
| US20240108719A1 (en) | Allergy antigen and epitope thereof | |
| Dechamma et al. | Identification of T-helper and linear B epitope in the hypervariable region of nucleocapsid protein of PPRV and its use in the development of specific antibodies to detect viral antigen | |
| Ludwig et al. | The cerebrospinal fluid of rabbits infected with Borna disease virus | |
| KR101510376B1 (en) | Shrimp allergen, anti-shrimp allergen antibody, and use thereof | |
| EP0518756B1 (en) | Procedure for the detection of a bovine viral diarrhoea virus infection, nucleotide sequence coding for a protein induced by infection with this virus, as well as recombinant proteins and antigens derived therefrom same | |
| KR930702942A (en) | Recombinant Cat Coronavirus S Protein | |
| Klinkert et al. | Cloning of diagnostic 31/32 kilodalton antigens of Schistosoma mansoni | |
| US20050287176A1 (en) | Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained | |
| Wei-Mei et al. | Mapping of monoclonal antibody binding sites on CNBr fragments of the S-layer protein antigens of Rickettsia typhi and Rickettsia prowazekii | |
| Harrison et al. | Identification of host-protective antigens of Taenia ovis oncospheres | |
| CA2089157A1 (en) | Liver fluke diagnostic system | |
| El Ridi et al. | T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium | |
| DE69106141T2 (en) | NON-A NON-B SEQUENCES. | |
| JP4830106B2 (en) | Trichinella species-specific antigen and method for testing Trichinella infection using the antigen | |
| Revilla-Nuín et al. | Partial characterization and isolation of 130 kDa antigenic protein of Dicrocoelium dendriticum adults | |
| JP2726264B2 (en) | Assays and antibodies for N-myc proteins | |
| Conley et al. | Localization of the human 64kD autoantigen D1 to myofibrils in a subset of extraocular muscle fibers | |
| Gaddum et al. | Identification of potential CTL epitopes of bovine RSV using allele-specific peptide motifs from bovine MHC class I molecules | |
| CA2256125C (en) | Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, useful for serologic diagnosis of canine leishmaniasis and protein obtained |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |